Mission Bio, Inc.
South San Francisco, CA Doing business as Mission Bio Inc. Mission Bio, Inc.
- UEI
- FCSLNELT6DG7
- CAGE
- 6GDM0
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 300 Utah Ave Suite 210, South San Francisco, CA 94080, USA
- Website
- missionbio.com
- Founded
- 2014
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Tapestri single-cell DNA + protein reagent kit V3 & tapestri single-cell DNA cartridge kit V3 mission BIO,… | Office of Logisitics and Acquisition Operations | $21,380 | |
| Mission BIO reagents kits mission BIO, INC.:1246876 [25-008875] | NIH Clinical Center | $22,755 | |
| Mission BIO reagent kits mission BIO, INC.:1246876 [25-008208] | NIH Clinical Center | $22,755 | |
| Mission BIO reagents kits mission BIO, INC.:1246876 [25-005913] | NIH Clinical Center | $22,755 | |
| Tapestri singlecell DNA + protein reagent kit | National Heart Lung and Blood Institute | $34,966 |
About Mission Bio, Inc.
Mission Bio, Inc., a for-profit manufacturer of single-cell genomics reagents and sequencing instruments based in South San Francisco, California, operates exclusively as a federal prime contractor (100% of awards) selling specialized biological supplies and sequencing kits to the National Institutes of Health through purchase orders, with no set-aside certifications and no subcontractor footprint. The company competes full-and-open across NIH institutes and does not hold positions on multi-award vehicles or governmentwide contracts.
Mission Bio's customer concentration is narrow and heavily skewed toward the National Institutes of Health. The National Heart Lung and Blood Institute (NHLBI) anchors the portfolio with 16 awards representing $661 thousand in combined potential value, followed by the NIH Clinical Center with 8 awards and $428 thousand. These two customers alone account for 79% of recent awards. Other NIH institutes—the National Institute on Aging, National Cancer Institute, and National Institute of Dental and Craniofacial Research—account for the remaining funding within HHS. The National Science Foundation and other HHS offices round out a five-customer set representing 97% of combined potential value across the portfolio. All purchase orders are firm fixed-price, with completion dates typically ranging between six and eighteen months from award.
Recent representative work includes a $21,380 purchase order from the NIH Clinical Center (May 2026) for Tapestri Single-Cell DNA + Protein Reagent Kit V3 and Tapestri Single-Cell DNA Cartridge Kit V3, completing in November 2026; a $67,980 NHLBI purchase order (September 2024) for "Clonal Evolution of Driver Mutations in Patients" services; a $166,729 NHLBI contract (August 2023) for genomic analysis services in clonal evolution; and a $138,625 National Institute on Aging order (June 2023) for a Tapestri Multiome Sequencing Instrument. Mission Bio's core capability is manufacturing and supplying single-cell DNA and protein sequencing reagent kits, proof-of-principle kits, custom genomics panels, and sequencing instruments that enable NIH researchers to conduct single-cell level genetic analysis in hematology, oncology, infectious disease, and personalized medicine research.
Award volume has declined from seven orders in 2023 to one in 2026 through May. The company faces a recompete cliff with three awards (combined potential value $67 thousand) completing within the next twenty-four months. Mission Bio's awards span research-and-development-focused NAICS categories (Biotechnology Research and Development dominates with 20 awards) and PSC codes centered on laboratory equipment and supplies (11 awards) and in-vitro diagnostic substances and reagents (6 awards). The combined potential value across all 39 awards stands at $1.3 million, though obligated dollars ($6.9 million) exceed that figure, indicating awards with multiple exercised options or multiple purchase orders under a standing relationship rather than an IDIQ vehicle.
Quick answers
What is Mission Bio, Inc.'s UEI?
Mission Bio, Inc.'s Unique Entity ID (UEI) in SAM.gov is FCSLNELT6DG7.
What is Mission Bio, Inc.'s CAGE code?
Mission Bio, Inc.'s CAGE code is 6GDM0.
What is Mission Bio, Inc.'s primary NAICS code?
Mission Bio, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Mission Bio, Inc. located?
Mission Bio, Inc.'s physical address in SAM.gov is 300 Utah Ave Suite 210, South San Francisco, CA 94080, USA.
Is Mission Bio, Inc. registered in SAM.gov?
Yes. Mission Bio, Inc.'s SAM.gov registration is active through April 7, 2027.
What is Mission Bio, Inc.'s most recent federal award?
Mission Bio, Inc.'s most recent federal contract award is Tapestri single-cell DNA + protein reagent kit V3 & tapestri single-cell DNA cartridge kit V3 mission BIO,… (75N98026P00514), from Office of Logisitics and Acquisition Operations, on May 28, 2026.
On GovTribe
See Mission Bio, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors